| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $37.2M | — | +0.1% |
| Cost of Revenue | $24.3M | — | -36.8% |
| Gross Profit | $12.8M | — | +1036.6% |
| R&D Expense | $19.6M | — | -32.5% |
| SG&A Expense | $31.2M | — | -22.4% |
| Operating Income | -$8.4M | — | +98.1% |
| Pre-tax Income | -$8.1M | — | +98.1% |
| Income Tax | $184K | — | +160.9% |
| Net Income | -$8.3M | — | +98.1% |
| EPS (Basic) | -$0.03 | — | +97.9% |
| EPS (Diluted) | -$0.03 | — | +97.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $56.3M | -11.7% | -3.8% |
| Short-term Investments | $219.7M | +1.8% | -22.8% |
| Accounts Receivable | $29.4M | -17.2% | -7.3% |
| Inventory | $51.0M | +3.5% | -5.5% |
| Current Assets | $369.5M | -1.5% | -16.9% |
| Total Assets | $782.4M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$44.7M | — | -1.4% |
| Capital Expenditures | $3.0M | — | +119.1% |
| Investing Cash Flow | $35.9M | — | -20.7% |
| Financing Cash Flow | $1.4M | — | -26.6% |
| Free Cash Flow | -$47.7M | — | -5.0% |
| -9.1% |
| Current Liabilities | $65.4M | -10.3% | -1.9% |
| Total Liabilities | $780.0M | +0.2% | +1.4% |
| Stockholders' Equity | $2.4M | -55.8% | -97.4% |